NeuroPsyAi

NeuroPsyAi - Precision in neuropsychiatry We provide clinicians (neurologists, psychiatrists and neuroradiologists) with patient-personalized reports that help them make early and accurate diagnoses of various neuropsychiatric disorders. Medical signals and images (such as electroencephalography - EEG, magnetic resonance imaging - MRI, and positron-emission tomography - PET) from patients are processed using our proprietary software engine and are statistically compared with large databases of patient and healthy subjects data using artificial intelligence (AI) algorithms in order to derive a risk probability of a particular patient having or developing a particular neuropsychiatric disorder (e.g. Alzheimer's Disease, Parkinson's Disease, Schizophrenia, Autism). NeuroPsyAi's analysis pipeline is automated, with a report being produced in a few hours since we receive the patient's data. Given the high sensitivity and specificity of our approach, subtle changes in brain structure and function can be detected early and accurately at the disease onset, enabling clinicians to diagnose and, thus, treat patients earlier and with more confidence. We aim to replace the so far relatively subjective and metrics-independent practice of psychiatry and neurology with a more quantified, objective, accurate and personalize one.